US FDA and CTTI pick patient advocates to boost engagement in trials Posted on July 16, 2018June 21, 2021 by Hannah Faulkner US FDA and CTTI pick patient advocates to boost engagement in trials
Collaboration and Transparency Key to More Effective Clinical Research Posted on March 30, 2018June 21, 2021 by Hannah Faulkner Collaboration and Transparency Key to More Effective Clinical Research
CTTI: Transforming clinical trials is going to take continued dedication, collaboration, and innovation Posted on February 13, 2018June 21, 2021 by Hannah Faulkner CTTI: Transforming clinical trials is going to take continued dedication, collaboration, and innovation
More Streamlined Clinical Research Arises from Collaborative Effort Posted on February 12, 2018June 21, 2021 by Hannah Faulkner More Streamlined Clinical Research Arises from Collaborative Effort
CTTI: Instituting Quality Measures Early in Trial Design Pays Off in the Long Run Posted on February 12, 2018June 21, 2021 by Hannah Faulkner CTTI: Instituting Quality Measures Early in Trial Design Pays Off in the Long Run
CTTI Recommendations Look to Lure ‘One and Done’ Investigators Back into the Fold Posted on October 18, 2017June 21, 2021 by Hannah Faulkner CTTI Recommendations Look to Lure ‘One and Done’ Investigators Back into the Fold
CTTI suggests ways to prevent ‘one and done’ syndrome in trial investigators Posted on October 11, 2017June 21, 2021 by Hannah Faulkner CTTI suggests ways to prevent ‘one and done’ syndrome in trial investigators
How to reduce clinical trial site investigator turnover Posted on October 10, 2017June 21, 2021 by Hannah Faulkner How to reduce clinical trial site investigator turnover
Proactive pregnancy testing planning to improve safety, efficacy of clinical trials Posted on September 11, 2017June 21, 2021 by Hannah Faulkner Proactive pregnancy testing planning to improve safety, efficacy of clinical trials
Drug Regulation and Pricing — Can Regulators Influence Affordability? Posted on May 12, 2016June 21, 2021 by Hannah Faulkner Drug Regulation and Pricing — Can Regulators Influence Affordability?
